28 studies found for:    Open Studies | "Blindness"
Show Display Options
Rank Status Study
21 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
22 Recruiting Revacept in Symptomatic Carotid Stenosis (Revacept/CS/02)
Conditions: Carotid Stenosis;   Atherosclerosis;   Stroke;   Transient-ischaemic Attack;   TIA;   Amaurosis Fugax
Interventions: Drug: Revacept;   Drug: Placebo
23 Recruiting Tracking Neurodegeneration in Early Wolfram Syndrome
Conditions: Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
Intervention:
24 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
25 Recruiting Patient Registry of Blind Subjects With Sleep-related Problems
Condition: Sleep-wake Disorder in Blind Individuals
Intervention: Other: Data collection on blindness and sleep problems
26 Recruiting Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Condition: Non 24 Hour Sleep Wake Disorder
Intervention: Drug: tasimelteon
27 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
28 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-28) Next Page   
Indicates status has not been verified in more than two years